Literature DB >> 19631293

The action of falciparum malaria on the human and chimpanzee genomes compared: absence of evidence for a genomic signature of malaria at HBB and G6PD in three subspecies of chimpanzee.

T S MacFie1, E Nerrienet, R E Bontrop, N I Mundy.   

Abstract

The historical association between Plasmodium and primates has meant that many Plasmodium species have coevolved with specific primate hosts. However, unlike humans that are infected by species such as P. falciparum that cause severe malaria, many non-human primates are infected by Plasmodium species that only cause mild disease. Here we investigate whether the genomic signatures of plasmodial infection found in humans are also present in chimpanzees. We find no evidence of the major deleterious mutations at HBB (beta-globin) and G6PD in chimpanzees that confer resistance to malaria caused by P. falciparum nor evidence of long-term balancing selection at these loci. Our knowledge of malaria prevalence and pathogenesis in wild chimpanzees is severely limited, but it may be the case that beta-globin and G6PD variation are not adaptive in chimpanzees because malaria is rare and/or less detrimental in this species. Alternatively, chimpanzees may utilise mechanisms that are different from those of humans to protect against malaria.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19631293     DOI: 10.1016/j.meegid.2009.06.025

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  3 in total

Review 1.  Population genetics of malaria resistance in humans.

Authors:  P W Hedrick
Journal:  Heredity (Edinb)       Date:  2011-03-23       Impact factor: 3.821

2.  The SLC4A1 gene is under differential selective pressure in primates infected by Plasmodium falciparum and related parasites.

Authors:  Michael E Steiper; Fiona Walsh; Julia M Zichello
Journal:  Infect Genet Evol       Date:  2012-03-08       Impact factor: 3.342

Review 3.  Resistance to malaria in humans: the impact of strong, recent selection.

Authors:  Philip W Hedrick
Journal:  Malar J       Date:  2012-10-22       Impact factor: 2.979

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.